This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

10 Bank Stocks Turning the Credit Corner

3. CapitalSource

Shares of CapitalSource (CSE) of Chevy Chase, Md., closed at $6.25 Wednesday, down 12% year-to-date.

The company had $9.3 billion in total assets as of June 30, with a nonperforming assets ratio of 7.36%, declining from 9.04% the previous quarter. Nonperforming assets information was not available for Capital Source for June 2010.

CapitalSource earned $16.6 million during the second quarter, or five cents a share, declining from $18.3 million, or six cents a share, in the second quarter of 2010, when the company booked a $21.7 million gain on the sale of all of its direct real estate investments, including sold 103 long-term care facilities to Omega Healthcare Investors.

CapitalSource remains focused on lending to the healthcare industry, as well as on equipment finance, technology, multifamily lending, and a professional practice lending group, which finances the acquisition of dental and veterinary practices.

The second-quarter provision for loan loss reserves was $1.5 million, declining from $25.3 million a year earlier.

On Sept. 15, after the company gained the consent of investors holding senior notes due in 2014, to increase its share repurchase authorization to $385 million from $200 million, and Jeff Davis of Guggenheim Securities reiterated his neutral rating on the shares, with a price target of $6.75.

The shares trade for 15 times the consensus 2012 EPS estimate of 42 cents, among analysts polled by FactSet, and just above their June 30 tangible book value of $5.99, according to SNL.

Out of 10 analysts covering CapitalSource, seven rate the shares a buy, while the remaining analysts all have neutral ratings.
9 of 11

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
BPOP $24.30 -3.11%
BAC $12.04 -7.00%
CSE $15.50 -0.51%
FBC $18.00 1.29%
PNC $81.77 -2.15%


Chart of I:DJI
DOW 16,027.05 -177.92 -1.10%
S&P 500 1,853.44 -26.61 -1.42%
NASDAQ 4,283.7530 -79.3910 -1.82%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs